Meral Beksac

14.4k citations
209 papers · 10.3k · 6 hit papers · h-index 36

Impact in

  • Hematology top 0.05%
    • Multiple Myeloma Research and Treatments
  • Oncology top 0.5%
    • Peptidase Inhibition and Analysis
    • Cancer Treatment and Pharmacology

Papers in

    • Multiple Myeloma Research and Treatments 116
    • Hematopoietic Stem Cell Transplantation 19
    • Acute Myeloid Leukemia Research 16
    • Peptidase Inhibition and Analysis 29
    • Cancer Treatment and Pharmacology 25

Meral Beksac

189 papers receiving 10.0k citations

Meral Beksac's Hit Papers

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma 2023 · 348 citations
3480+4+9Years since publication10002.0k3.0k

Peers

Meral Beksac
Comparison fields: 5 of 125
  • Hematology 7.7k
  • Oncology 3.7k
  • Genetics 1.1k
  • Molecular Biology 4.6k
  • Pathology and Forensic Medicine 422
Replace Jo Caers with:
Jo Caers Belgium
Kazuyuki Shimizu Japan
Francesca Gay Italy
Patrizia Tosi Italy
Martin Kaiser United Kingdom
Athanasios Fassas United States
Michel Delforge Belgium
Suzanne Lentzsch United States
Natalie S. Callander United States
Brendan M. Weiss United States
Meral Beksac relative to Jo Caers Belgium Jo Caers's profile →
Citations per field
00.5×1.6×
Jo Caers · 1×
Citations per year

Countries citing papers authored by Meral Beksac

Since Specialization
Citations

This map shows the geographic impact of Meral Beksac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meral Beksac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meral Beksac more than expected).

Fields of papers citing papers by Meral Beksac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meral Beksac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meral Beksac. The network helps show where Meral Beksac may publish in the future.

Co-authors

The 25 scholars most cited alongside Meral Beksac, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Meral Beksac Line = papers co-authored together Meral Beksac links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 209 papers — load more, or switch the sort, to bring in the rest.

#Work
1
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Hit paper breakdown →
20143585
2
Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
Hit paper breakdown →
2012636
3
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Hit paper breakdown →
2015441
4 2011361
5
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Hit paper breakdown →
2023348
6
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2019316
7 2017300
8 2011234
9 2011222
10 2021208
11 2018195
12 2018190
13 2014165
14 2012161
15 2020148
16 2013145
17
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
Hit paper breakdown →
2023140
18 2010132
19 2016127
20 2021125

About Meral Beksac

Meral Beksac is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 209 papers that have together received 10.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (116 papers), Protein Degradation and Inhibitors (40 papers), Peptidase Inhibition and Analysis (29 papers), Cancer Treatment and Pharmacology (25 papers), Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (16 papers), Cancer therapeutics and mechanisms (14 papers) and Acute Lymphoblastic Leukemia research (13 papers). The work is most often cited by research in Hematology (7.7k citations), Oncology (3.7k citations), Genetics (1.1k citations), Molecular Biology (4.6k citations) and Pathology and Forensic Medicine (422 citations). Meral Beksac has collaborated with scholars based in Türkiye, United States and Netherlands. Frequent co-authors include Philippe Moreau, Pieter Sonneveld, Meletios Athanasios Dimopoulos, Osman İlhan, Rauf Haznedar, Mutlu Arat, Jesús F. San Miguel, Hamdi Akan, Artur J. Jurczyszyn and Ye Yang. Their work appears in journals such as Blood, HemaSphere, Bone Marrow Transplantation, Leukemia and Transplantation and Cellular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact